MedPath

ifestyle intervention in men with advanced prostate cancer receiving androgen suppression therapy

Completed
Conditions
Men with advanced prostate cancer receiving androgen suppression therapy
Cancer
Malignant neoplasm of prostate
Registration Number
ISRCTN88605738
Lead Sponsor
Sheffield Teaching Hospitals NHS Foundation Trust (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Male
Target Recruitment
100
Inclusion Criteria

1. Histologically confirmed, non-localised prostate cancer (PCa)
2. Stable disease (stable prostate specific antigen [PSA])
3. Receiving Androgen suppression therapy (AST) for a minimum period of six months
4. A willingness to comply with the randomised allocation to intervention and willing to undertake the requirements of the allocated intervention. If allocated to the exercise intervention, willing to aim to achieve 80% compliance to the exercise intervention.

Exclusion Criteria

1. Participation in regular physical activity (defined as purposeful physical activity of a moderate intensity for 30 minutes three or more times per week in the previous six months)
2. Unstable angina, uncontrolled hypertension, recent myocardial infarction, pacemakers
3. Uncontrolled painful or unstable bone lesions
4. Less than two months post surgical treatment
5. Any physical, neurological or psychiatric impairment or disease such as dementia, multiple sclerosis, severe arthritis or other condition that would limit the ability to understand and complete the study exercises and complete the required questionnaires, recall and record of dietary information

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Current primary outcome measures as of 12/07/2013:<br>To be measured at baseline, 12 and 26 weeks:<br>1. Quality of life measured using the FACTP questionnaire<br>2. Diastolic blood pressure measured using an automated sphygmomanometer<br><br>Previous primary outcome measures:<br>1. Exercise behaviour measured using the Godin Leisure Score Index questionnaire at baseline, 12 weeks and 6 months of follow-up<br>2. Dietary intake measured using three day diet diaries over the intervention period
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath